- Home
- DARE vs AACG Comparison
DARE vs AACG Comparison
Compare DARE & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- AACG
- Stock Information
- Founded
- DARE 2015
- AACG 1999
- Country
- DARE United States
- AACG China
- Employees
- DARE N/A
- AACG N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- AACG Other Consumer Services
- Sector
- DARE Health Care
- AACG Real Estate
- Exchange
- DARE Nasdaq
- AACG Nasdaq
- Market Cap
- DARE 26.3M
- AACG 24.4M
- IPO Year
- DARE N/A
- AACG N/A
- Fundamental
- Price
- DARE $2.20
- AACG $1.96
- Analyst Decision
- DARE Strong Buy
- AACG
- Analyst Count
- DARE 1
- AACG 0
- Target Price
- DARE $12.00
- AACG N/A
- AVG Volume (30 Days)
- DARE 340.6K
- AACG 690.5K
- Earning Date
- DARE 08-14-2025
- AACG 08-06-2025
- Dividend Yield
- DARE N/A
- AACG N/A
- EPS Growth
- DARE N/A
- AACG N/A
- EPS
- DARE N/A
- AACG N/A
- Revenue
- DARE N/A
- AACG $39,064,701.00
- Revenue This Year
- DARE $74,787.57
- AACG N/A
- Revenue Next Year
- DARE $141.76
- AACG N/A
- P/E Ratio
- DARE N/A
- AACG N/A
- Revenue Growth
- DARE N/A
- AACG 15.19
- 52 Week Low
- DARE $1.83
- AACG $0.50
- 52 Week High
- DARE $9.19
- AACG $2.30
- Technical
- Relative Strength Index (RSI)
- DARE 43.48
- AACG 60.72
- Support Level
- DARE $1.83
- AACG $1.42
- Resistance Level
- DARE $2.50
- AACG $2.13
- Average True Range (ATR)
- DARE 0.15
- AACG 0.38
- MACD
- DARE -0.01
- AACG 0.04
- Stochastic Oscillator
- DARE 50.68
- AACG 72.58
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.